• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

    9.610 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Intellia Therapeutics, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    20 21 Next >
    News headline image
    How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint ↗
    Shares of BridgeBio Pharma are nearing a record high as the small biotech company takes on drug behemoths Pfizer and Alnylam. 
    Via Investor's Business Daily
    News headline image
    Intellia (NTLA) Q3 2025 Earnings Call Transcript ↗
    Intellia (NTLA) Q3 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
    From MarketNewsUpdates.com
    Via GlobeNewswire
    News headline image
    2 Beaten-Down Stocks to Avoid Right Now ↗
    There might be plenty more downside for these biotechs. 
    Via The Motley Fool
    Topics Death
    News headline image
    Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
    EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:NTLA),(NASDAQ:ZYME),(NYSE:ANVS) EQNX::TICKER_END 
    Via FinancialNewsMedia
    News headline image
    This Bath & Body Works Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday ↗
     
    Via Benzinga
    News headline image
    This SPS Commerce Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday ↗
     
    Via Benzinga
    News headline image
    What 21 Analyst Ratings Have To Say About Intellia Therapeutics ↗
     
    Via Benzinga
    News headline image
    Why Gene-Editing Giants Crispr And Intellia Just Surged ↗
    The companies are working on one-and-done treatments for diseases tied to genetic problems. 
    Via Investor's Business Daily
    Topics Death
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies ↗
    The company remains confident in its other gene-editing product, which would treat a swelling disorder. 
    Via Investor's Business Daily
    Topics Death
    News headline image
    2 Small-Cap Stocks With Far More Upside Than Any "Magnificent Seven" Stock, According to Wall Street ↗
    Wall Street may be overestimating these companies' potential. 
    Via The Motley Fool
    News headline image
    Discover the top movers in Friday's pre-market session. ↗
    As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Block Posts Downbeat Q3 Results, Joins Archer Aviation, DraftKings And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Intellia Therapeutics Inc (NASDAQ:NTLA) Plummets 24.5% After FDA Places Clinical Hold on Phase 3 Trials ↗
    Intellia stock plunges after FDA places clinical hold on its Phase 3 trials for lead candidate nex-z, overshadowing Q3 earnings. 
    Via Chartmill
    News headline image
    What's going on in today's after hours session ↗
    Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics. 
    Via Chartmill
    News headline image
    AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures
    A groundbreaking $2 million grant from the National Institutes of Health (NIH) is set to dramatically accelerate advancements in gene-editing technology, with artificial intelligence (AI) emerging as... 
    Via TokenRing AI
    Topics Artificial Intelligence Climate Change Intellectual Property
    News headline image
    Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More Than 130% ↗
    Maybe Cathie Wood and Wall Street are being too optimistic. 
    Via The Motley Fool
    Topics Death
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Meta, eBay, Microsoft And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    What's going on in today's after hours session ↗
    The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today. 
    Via Chartmill
    News headline image
    Intellia Therapeutics Stock Is Diving Again: Here's Why ↗
    Intellia Therapeutics shares are tumbling in after-hours trading on Wednesday. Here's what you need to know. 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Nucor To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
     
    Via Benzinga
    News headline image
    This Boot Barn Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗
     
    Via Benzinga
    News headline image
    Which stocks are moving on Monday? ↗
    Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
    Via Chartmill
    News headline image
    Qualcomm, Tesla, Intellia Therapeutics, Avidity Biosciences, Dyne Therapeutics: Stocks Making The Biggest Moves Today ↗
    Qualcomm shares were up more than 11% in Monday’s midday session after the company unveiled two AI accelerator chips. 
    Via Stocktwits
    Topics Artificial Intelligence ETFs Government
    News headline image
    Keep an eye on the top gainers and losers in Monday's session. ↗
    Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session. 
    Via Chartmill
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    20 21 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.